NAVELLIER & ASSOCIATES INC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 115 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NAVELLIER & ASSOCIATES INC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2019$861,000
-11.6%
16,082
-1.4%
0.14%
-6.0%
Q2 2019$974,000
-0.8%
16,309
+3.5%
0.15%
-0.7%
Q1 2019$982,000
+244.6%
15,755
+235.2%
0.15%
+216.7%
Q4 2018$285,000
-42.3%
4,700
-59.1%
0.05%
-11.1%
Q4 2015$494,000
-19.0%
11,488
-18.1%
0.05%
-11.5%
Q3 2015$610,000
+23.0%
14,020
+46.0%
0.06%
+38.6%
Q2 2015$496,000
+26.9%
9,606
-3.7%
0.04%
+25.7%
Q1 2015$391,000
-18.2%
9,975
-19.4%
0.04%
+45.8%
Q4 2014$478,000
+8.1%
12,382
-1.2%
0.02%
+9.1%
Q3 2014$442,00012,5310.02%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 211,370$9,833,0005.80%
JW Asset Management, LLC 73,649$3,426,0002.51%
NORTHPOINTE CAPITAL LLC 135,657$6,311,0000.67%
Elk Creek Partners, LLC 170,102$7,913,0000.50%
RICE HALL JAMES & ASSOCIATES, LLC 156,167$7,265,0000.32%
Ativo Capital Management LLC 22,592$1,051,0000.28%
Matarin Capital Management, LLC 59,077$2,748,262,0000.23%
ISTHMUS PARTNERS, LLC 16,753$779,0000.22%
CADENCE CAPITAL MANAGEMENT LLC 29,586$1,376,0000.09%
ALGERT GLOBAL LLC 7,834$364,0000.08%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders